首页> Anticancer research> Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.

Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Marija,Ger

第一单位： Institute of Biochemistry, Proteomics Center, Vilnius University Life Sciences Center, Vilnius, Lithuania marija.ger@bchi.vu.lt.

作者： Marija,Ger ^[1] ; Algirdas,Kaupinis ^[2] ; Marius,Petrulionis ^[3] ; Benediktas,Kurlinkus ^[4] ; Jonas,Cicenas ^[5] ; Audrius,Sileikis ^[3] ; Mindaugas,Valius ^[2] ; Kestutis,Strupas ^[3]

作者单位： Institute of Biochemistry, Proteomics Center, Vilnius University Life Sciences Center, Vilnius, Lithuania marija.ger@bchi.vu.lt. ^[1] Institute of Biochemistry, Proteomics Center, Vilnius University Life Sciences Center, Vilnius, Lithuania. ^[2] Center of Abdominal Surgery, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.;Clinic of Gastroenterology, Nephrourology and Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. ^[3] Clinic of Gastroenterology, Nephrourology and Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. ^[4] Institute of Biochemistry, Proteomics Center, Vilnius University Life Sciences Center, Vilnius, Lithuania.;MAP Kinase Resource, Bioinformatics, Bern, Switzerland.;Department of Microbiology, Immunology and Genetics, Max F. Perutz Laboratories, University of Vienna, Vienna, Austria. ^[5]

关键词 Pancreatic cancer biomarkers proteomic analysis